Follow Us TR

News Details

PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials

About PRA Group, Inc.
  • NASDAQ: $PRAA
  • Notified: $40.86
  • 08:30 EDT

Price Chart